Conviction in Complexity

Finding conviction in complex science is not about moving faster. It is about going deeper.

In Finding Conviction in Complexity, members from Genoa Ventures explains how they build confidence in scientific and commercial ideas that most investors struggle to evaluate. These are companies operating at the edge of what is known, where both the technology and the business model are still taking shape.

Genoa works alongside founders for months and sometimes years, studying the science, shaping strategy, and testing assumptions before capital is committed. This long view allows risk to be addressed early and partnerships to form before the pressure of scale begins.

In this video, Jenny Rooke, Managing Director and Vikram Chaudhery, Partner share why the most important work happens before an investment is made. Founders from Alida Biosciences, Codetta Bio, SimBioSys, Meiogenix, and Aqtual describe what it means to work with an investor that takes the time to truly understand complex technology and help turn it into clear direction.

After investment, that understanding carries into the boardroom, where Genoa stays closely involved in decision-making as companies grow. This is a look at how conviction in difficult science is built through time, technical insight, and close collaboration with founders.